These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8572899)

  • 41. Donor-specific transfusion via the portal venous route induces prolongation of H-2-compatible but not H-2-incompatible cardiac graft survival.
    Górecki D; Jakóbisiak M; Lupińska M; Kruszewski A; Czyźyk J
    Transpl Int; 1989 Dec; 2(4):199-202. PubMed ID: 2627262
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Failure of azathioprine and steroids to augment one-day-pretransplant donor-specific transfusion-enhanced allograft survival.
    Madden RL; Brunson ME; Alexander JW; Davies CB
    Transplantation; 1993 Jun; 55(6):1436-8. PubMed ID: 8516833
    [No Abstract]   [Full Text] [Related]  

  • 43. Transfusions of syngeneic blood do not seem to induce suppressive effect on antitumor or transplantation immunity in mice.
    Jakóbisiak M; Włodarski K; Lasek W; Górecki D; Płodziszewska M
    Arch Immunol Ther Exp (Warsz); 1985; 33(4):543-7. PubMed ID: 3909991
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Examination of the clonal deletion hypothesis following transfusions in rat cardiac transplants.
    Takiff H; Novak M; Yin L; Iwaki Y; Terasaki PI
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1452-4. PubMed ID: 3274352
    [No Abstract]   [Full Text] [Related]  

  • 45. The influence of pretransplant and posttransplant immunosuppression on cardiac graft survival in the donor-specific transfusion model in mice. Comparison of the effects of cyclophosphamide, procarbazine, cyclosporine, and cortisone.
    Lasek W; Jakóbisiak M; Grochowska M; Górecki D; Gniadecki R; Kaliński P
    Transplantation; 1989 May; 47(5):913-5. PubMed ID: 2655232
    [No Abstract]   [Full Text] [Related]  

  • 46. Inhibition of terminal complement components in presensitized transplant recipients prevents antibody-mediated rejection leading to long-term graft survival and accommodation.
    Wang H; Arp J; Liu W; Faas SJ; Jiang J; Gies DR; Ramcharran S; Garcia B; Zhong R; Rother RP
    J Immunol; 2007 Oct; 179(7):4451-63. PubMed ID: 17878341
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sensitization following donor-specific transfusions detected by 51Cr release assays--CyA modulation of early rejection effects.
    Birtch AG; McConnachie P; Lewis WI
    Transplant Proc; 1987 Feb; 19(1 Pt 1):805-7. PubMed ID: 3079166
    [No Abstract]   [Full Text] [Related]  

  • 48. Are DST/allograft-induced suppressor cells donor specific?
    Wakely E; Cutkomp J; Corry RJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):488-90. PubMed ID: 2523147
    [No Abstract]   [Full Text] [Related]  

  • 49. Avenues for acquired immune tolerance.
    Wood KJ; Morris PJ
    Semin Thorac Cardiovasc Surg; 1990 Apr; 2(2):189-97. PubMed ID: 2081227
    [No Abstract]   [Full Text] [Related]  

  • 50. Is recipient priming with graft foreign antigen a prerequisite for the blood transfusion effect?
    Corry RJ; Shelby J; David C; Heffner C; Billingsley A; Kelley SE
    Transplant Proc; 1982 Jun; 14(2):391-3. PubMed ID: 6180531
    [No Abstract]   [Full Text] [Related]  

  • 51. Immunosuppression in the baboon cardiac allograft model: effects of splenectomy, bolus methylprednisolone, propranolol, high-dose azathioprine, cyclophosphamide, and a niridazole metabolite.
    Cooper DK; Novitzky D; Lanza RP; Rose AG; Wicomb WN; Barnard CN
    Transplantation; 1984 Sep; 38(3):299-301. PubMed ID: 6382717
    [No Abstract]   [Full Text] [Related]  

  • 52. Estradiol enhances murine cardiac allograft rejection under cyclosporin and can be antagonized by the antiestrogen tamoxifen.
    Zou Y; Steurer W; Klima G; Obrist P; Margreiter R; Brandacher G
    Transplantation; 2002 Aug; 74(3):354-7. PubMed ID: 12177613
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of cyclosporine, donor-specific transfusion, and antilymphocyte serum suppression of skin, heart, and fetal pancreatic islet allograft rejection in mice.
    Mason A; Mottram PL; Mirisklavos A; Clurne GJ; Mandel TE
    Transplantation; 1988 Jun; 45(6):1155-7. PubMed ID: 3132766
    [No Abstract]   [Full Text] [Related]  

  • 54. C5 blockade with conventional immunosuppression induces long-term graft survival in presensitized recipients.
    Rother RP; Arp J; Jiang J; Ge W; Faas SJ; Liu W; Gies DR; Jevnikar AM; Garcia B; Wang H
    Am J Transplant; 2008 Jun; 8(6):1129-42. PubMed ID: 18444931
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyclosporine A: graft survival and cardiotoxicity in murine cardiac allografts.
    Mirisklavos A; Mottram PL; Smith JA; Mason A; Dumble LJ; Clunie GJ; Panagiotopoulos S; Nayler WG
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1259-61. PubMed ID: 3274313
    [No Abstract]   [Full Text] [Related]  

  • 56. Long-term cardiac allograft survival in mice treated with malononitrilamide 715.
    Gerauer K; Maier S; Emmanuilidis K; Chambron N; Zantl N; Pfeffer K; Heidecke CD
    Transplant Proc; 1998 Dec; 30(8):4205-6. PubMed ID: 9865349
    [No Abstract]   [Full Text] [Related]  

  • 57. Donor pretreatment with cyclophosphamide interferes with the enhancing effect of blood transfusion in rats.
    Marquet RL; Heystek GA; van Es AA
    Transplant Proc; 1981 Mar; 13(1 Pt 1):525-7. PubMed ID: 7022887
    [No Abstract]   [Full Text] [Related]  

  • 58. Prolongation of mouse heart allograft survival by prior administration of nonspecific blood.
    Kelley SE; Corry RJ
    Transplant Proc; 1981 Mar; 13(1 Pt 1):518-22. PubMed ID: 7022885
    [No Abstract]   [Full Text] [Related]  

  • 59. Studies on the control of hyperacute rejection in hyperimmunized rat: combination of donor specific blood transfusion (DST) and immunosuppressive drugs.
    Dohi K; Tabe Y; Ono E; Ezaki H
    Hiroshima J Med Sci; 1985 Mar; 34(1):137-46. PubMed ID: 4019235
    [No Abstract]   [Full Text] [Related]  

  • 60. Improved graft survival after concanavalin A donor and graft pretreatment in sensitized recipients.
    Rodriguez S; Toledo-Pereyra LH; Castellanos J; Finkelstein I
    Transplant Proc; 1988 Oct; 20(5):959-61. PubMed ID: 3055541
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.